Konstantinidis I, et al. JAMA Intern Med 2016; 176:121–124.
P eople with kidney disease are medically complex, and kidney disease may have an impact on the development of therapies to treat the many comorbidities affecting this population. Cardiovascular disease is a common and significant comorbidity among these patients, and individuals with kidney disease make up a sizeable proportion (30% to 60%) of patients with cardiovascular disease (
The Kidney Health Initiative (KHI)